% | $
Quotes you view appear here for quick access.

VPHM Message Board

  • bionic_research bionic_research Sep 16, 2013 2:37 PM Flag

    Analysts Getting More Bullish On ViroPharma (article 9/16)

    Analysts Getting More Bullish On ViroPharma Following Friday's 28+% Surge On Takeover Chatter
    Paul Quintaro, Benzinga Staff Writer
    September 16, 2013 11:00 AM
    ViroPharma (NASDAQ: VPHM) shares are up about three-quarters of a percent Monday morning on the heels of a 28-plus percent move higher on Friday. Traders in the name were responding to chatter the company had received offers from both Sanofi (NYSE: SNY) and Shire (NASDAQ: SHPG).

    Monday morning numerous analysts are commenting and raising price targets on ViroPharma.

    ■Stifel Nicolaus raised target from $41 to $47, Buy rating maintained.
    ■Piper Jaffray target from $37 to $46, Overweight maintained.
    ■Oppenheimer target from $35 to $44, Outperform maintained.
    ■Mizuho sees value of $45 assuming cost savings if M&A does happen, believes could include a contingent value of $2-3/share related to cinryze.